Dillon H Miles

2PUBLICATIONS
2CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|May 23, 2025
Discovery of AB801, a Potent and Selective Inhibitor of AXL Receptor Tyrosine Kinase for Use in Cancer Therapy.

Dillon H Miles, Manjunath Lamani, Srinivas Reddy Paladugu

|May 23, 2025
Discovery and Characterization of Potent, Selective, and Orally Bioavailable 7-Azaindazole AXL Receptor Tyrosine Kinase Inhibitors.

Corinne N Foley, Shiwei Qu, Srinivas Reddy Paladugu

Pageof 1